Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004483
Status:
UNKNOWN
Last Update Posted:
2005-09-29
First Post:
1999-10-18
Brief Title:
NF2 Natural History Consortium
Sponsor:
House Ear Institute
Organization:
Office of Rare Diseases ORD
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES
I Define the growth rates and clinical course of NF2-related tumors in patients with neurofibromatosis type 2 Associate growth rate with physical function
I Define the growth rates and clinical course of NF2-related tumors in patients with neurofibromatosis type 2 Associate growth rate with physical function
Detailed Description:
PROTOCOL OUTLINE Data on the clinical course and growth rate of NF2-related tumors in patients with neurofibromatosis 2 Patients are evaluated each year on a cranial and a spinal MRI eye tests hearing tests quality of life neurological tests and physical functioning
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HEI-DAMD17-01-1-0710 | None | None | None |
| HEI-NF2 | None | None | None |